Cargando…

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews

Alzheimer’s disease (AD) is the most common form of dementia over the age of 65. It is estimated that 115.4 million people will be affected by AD by 2050. Acetylcholinesterase inhibitors (AChEI) are the only available and approved treatment for AD. The aim of the present study was to analyse the evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreta, Marta Pérez-Gómez, Burgos-Alonso, Natalia, Torrecilla, María, Marco-Contelles, José, Bruzos-Cidón, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615650/ https://www.ncbi.nlm.nih.gov/pubmed/34829917 http://dx.doi.org/10.3390/biomedicines9111689

Ejemplares similares

Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review
por: Moyaert, Paulien, et al.
Publicado: (2023)

Dysfunctional Inhibitory Mechanisms in Locus Coeruleus Neurons of the Wistar Kyoto Rat
por: Bruzos-Cidón, C, et al.
Publicado: (2015)

Deletion of GIRK2 Subunit of GIRK Channels Alters the 5-HT(1A) Receptor-Mediated Signaling and Results in a Depression-Resistant Behavior
por: Llamosas, Nerea, et al.
Publicado: (2015)

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
por: Bittner, Nadine, et al.
Publicado: (2023)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)

The Postoperative Effect of Sugammadex versus Acetylcholinesterase Inhibitors in Colorectal Surgery: An Updated Meta-Analysis
por: Vaghiri, Sascha, et al.
Publicado: (2023)

Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
por: Young, Sara, et al.
Publicado: (2021)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
por: Devita, Maria, et al.
Publicado: (2021)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study
por: Kim, Ha-Ri, et al.
Publicado: (2023)

A Novel Application of Multiscale Entropy in Electroencephalography to Predict the Efficacy of Acetylcholinesterase Inhibitor in Alzheimer's Disease
por: Tsai, Ping-Huang, et al.
Publicado: (2015)

Analgesic Efficacy of COX-2 Inhibitors in Periodontal Surgery: A Systematic Review and Meta-Analysis
por: Isiordia-Espinoza, Mario Alberto, et al.
Publicado: (2023)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors
por: Leinonen, Anne, et al.
Publicado: (2015)

Neural Mechanisms of Motor Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review
por: Koppelmans, Vincent, et al.
Publicado: (2022)

Leveraging mHealth and Virtual Reality to Improve Cognition for Alzheimer’s Patients: A Systematic Review
por: Kruse, Clemens Scott, et al.
Publicado: (2022)

Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
por: Chen, Michelle H., et al.
Publicado: (2020)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni, Giulia, et al.
Publicado: (2014)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
por: Son, Minky, et al.
Publicado: (2019)

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018)

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
por: Moss, Donald E.
Publicado: (2020)

Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022)

Volumetry of Olfactory Structures in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and a Meta-Analysis
por: Jobin, Benoît, et al.
Publicado: (2021)

Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Pereira, Meire Ellen, et al.
Publicado: (2022)

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zabala-Findlay, Alex, et al.
Publicado: (2023)

The Effects of Medium Chain Triglyceride for Alzheimer’s Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Sun, Lina, et al.
Publicado: (2023)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
por: Walczak-Nowicka, Łucja Justyna, et al.
Publicado: (2021)

Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis
por: Bezzio, Cristina, et al.
Publicado: (2023)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
por: Bhattacharya, Soumee, et al.
Publicado: (2015)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2020)

Discovery of new acetylcholinesterase inhibitors for Alzheimer’s disease: virtual screening and in vitro characterisation
por: David, Benoit, et al.
Publicado: (2021)

Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Simion, Laurentiu, et al.
Publicado: (2023)

Effects of Transcranial Direct Current Stimulation on Memory of Elderly People with Mild Cognitive Impairment or Alzheimer’s Disease: A Systematic Review
por: da Silva, Eliclebysson Rodrigo, et al.
Publicado: (2022)

The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhang, Shiyan, et al.
Publicado: (2022)

Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
por: Lacorte, Eleonora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fp4sr7clr7liqvdne5kms7m6pk